Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
Injury ; 52(10): 2803-2812, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34391576

ABSTRACT

INTRODUCTION: Lamotrigine, an anticonvulsant drug with inhibition properties of multi-ion channels, has been shown to be able to attenuates secondary neuronal damage by influencing different pathways. The aim of this study was to look into whether lamotrigine treatment could protect the spinal cord from experimental spinal cord ischemia-reperfusion injury. MATERIALS AND METHODS: Thirty-two rats, eight rats per group, were randomly assigned to the sham group in which only laparotomy was performed, and to the ischemia, methylprednisolone and lamotrigine groups, where the infrarenal aorta was clamped for thirty minutes to induce spinal cord ischemia-reperfusion injury. Tissue samples belonging to spinal cords were harvested from sacrificed animals twenty-four hours after reperfusion. Tumor necrosis factor-alpha levels, interleukin-1 beta levels, nitric oxide levels, superoxide dismutase activity, catalase activity, glutathione peroxidase activity, malondialdehyde levels and caspase-3 activity were studied. Light and electron microscopic evaluations were also performed to reveal the pathological alterations. Basso, Beattie, and Bresnahan locomotor scale and the inclined-plane test was used to evaluate neurofunctional status at the beginning of the study and just before the animals were sacrificed. RESULTS: Lamotrigine treatment provided significant improvement in the neurofunctional status by preventing the increase in cytokine expression, increased lipid peroxidation and oxidative stress, depletion of antioxidant enzymes activity and increased apoptosis, all of which contributing to spinal cord damage through different paths after ischemia reperfusion injury. Furthermore, lamotrigine treatment has shown improved results concerning the histopathological and ultrastructural scores and the functional tests. CONCLUSION: These results proposed that lamotrigine may be a useful therapeutic agent to prevent the neuronal damage developing after spinal cord ischemia-reperfusion injury.


Subject(s)
Neuroprotective Agents , Reperfusion Injury , Spinal Cord Ischemia , Animals , Rats , Anticonvulsants/therapeutic use , Disease Models, Animal , Lamotrigine/therapeutic use , Neuroprotective Agents/pharmacology , Reperfusion Injury/drug therapy , Reperfusion Injury/prevention & control , Spinal Cord , Spinal Cord Ischemia/drug therapy
2.
Turk Neurosurg ; 31(5): 731-739, 2021.
Article in English | MEDLINE | ID: mdl-34169995

ABSTRACT

AIM: To analyze the expression of ADAMTS-1, NF-?B, and STAT3 in human pleomorphic xanthoastrocytoma specimens, and their correlation with glioma advancement. MATERIAL AND METHODS: Pleomorphic xanthoastrocytoma tumor cell lines were treated with low and high doses of cytokines at 24 and 48 hours (h) to replicate the inflammatory environment. The effects of IL-1 were assessed with the scratch wound-healing assay, and the expression levels of ADAMTS-1, NF-?B, and STAT3 of the groups were determined by western blot analysis. RESULTS: Cytokine treatment significantly increased the migration of PXA glioma cells after scratching at 24h and 48h time points. Similarly, 10 and 30 ng/mL IL-1 induced 1.86 and 1.94 fold increases, respectively, in ADAMTS-1 expression after 24h, and 3 and 3.27 fold increases, respectively, after 48h, compared with the non-treatment control group.10 and 30 ng/mL IL-1 doses caused 2.5 and 2.6 fold increase, in NF-?B protein levels after 24h, and 3.16 and 3.41 fold increases after 48h, compared with the non-treatment group. The protein levels of STAT3 after 24h were 2.62 and 2.43 fold higher, and 3.78 and 3.84 fold higher after 48 hours, with 10 and 30 ng/mL IL-1, compared with the non-treatment group. CONCLUSION: The proliferation and progression of glioma cells were proportional to the increased expression levels of ADAMTS-1, NF-?B, and STAT3. Our findings indicate that the proteolytic function of ADAMTS-1 may be associated with the malignant transformation of low-grade gliomas.


Subject(s)
ADAMTS1 Protein/metabolism , Astrocytoma , Glioma , Cell Transformation, Neoplastic , Cytokines , Humans
3.
World Neurosurg ; 150: e287-e297, 2021 06.
Article in English | MEDLINE | ID: mdl-33689849

ABSTRACT

OBJECTIVE: Inflammation and oxidative stress are 2 important factors in the emergence of paraplegia associated with spinal cord ischemia-reperfusion injury (SCIRI) after thoracoabdominal aortic surgery. Here it is aimed to investigate the effects of Ganoderma lucidum polysaccharide (GLPS) on SCIRI. METHODS: Rats were randomly selected into 4 groups of 8 animals each: sham, ischemia, methylprednisolone, and GLPS. To research the impacts of various pathways that are efficacious in formation of SCIRI, tumor necrosis factor α, interleukin 1ß, nitric oxide, superoxide dismutase levels, and catalase, glutathione peroxidase activities, malondialdehyde levels, and caspase-3 activity were measured in tissues taken from the spinal cord of rats in all groups killed 24 hours after ischemia reperfusion injury. The Basso, Beattie, and Bresnahan locomotor scale and inclined plane test were used for neurologic assessment before and after SCIRI. In addition, histologic and ultrastructural analyses of tissue samples in all groups were performed. RESULTS: SCIRI also caused marked increase in tissue tumor necrosis factor α, interleukin 1ß, nitric oxide, malondialdehyde levels, and caspase-3 activity, because of inflammation, increased free radical generation, lipid peroxidation, and apoptosis, respectively. On the other hand, SCIRI caused significant reduction in tissue superoxide dismutase, glutathione peroxidase, and catalase activities. Pretreatment with GLPS likewise diminished the level of the spinal cord edema, inflammation, and tissue injury shown by pathologic and ultrastructural examination. Pretreatment with GLPS reversed all these biochemical changes and improved the altered neurologic status. CONCLUSIONS: These outcomes propose that pretreatment with GLPS prevents progression of SCIRI by alleviating inflammation, oxidation, and apoptosis.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Polysaccharides/therapeutic use , Reishi/chemistry , Reperfusion Injury/drug therapy , Reperfusion Injury/pathology , Spinal Cord Injuries/drug therapy , Spinal Cord Injuries/pathology , Animals , Anti-Inflammatory Agents/therapeutic use , Antioxidants/metabolism , Apoptosis/drug effects , Disease Progression , Inflammation Mediators/metabolism , Locomotion , Male , Methylprednisolone/therapeutic use , Molecular Weight , Oxidative Stress/drug effects , Polysaccharides/chemistry , Rats , Rats, Sprague-Dawley , Spinal Cord/pathology , Spinal Cord/ultrastructure , Treatment Outcome
4.
Asian J Neurosurg ; 13(4): 1018-1025, 2018.
Article in English | MEDLINE | ID: mdl-30459860

ABSTRACT

PURPOSE: The aim of the present study was to investigate the effect of etanercept (ETA) on histopathological and biochemical changes after traumatic brain injury (TBI) in rats. MATERIALS AND METHODS: Thirty-six male Wistar albino rats were distributed into three groups (n = 12 each). Control group rats were not subjected to trauma. Trauma group rats were subjected to TBI only. ETA group rats were subjected to TBI plus ETA (5 mg/kg intraperitoneal [i.p.]). The groups were further subdivided into those sacrificed in the hyperacute stage (1 h after TBI) (control-1, trauma-1, and ETA-1 groups) and the acute stage (6 h after TBI) (control-6, trauma-6, and ETA-6 groups). Tissue levels of tumour necrosis factor-alpha, interleukin-1 beta, malondialdehyde, catalase, glutathione peroxidase, and superoxide dismutase were analyzed. Histopathological and ultrastructural evaluations were also performed. RESULTS: i.p. administration of ETA at 1 and 6 h significantly reduced inflammatory cytokine expression, attenuated oxidative stress and lipid peroxidation, prevented apoptosis, and increased antioxidant defense mechanism activity in comparison to trauma group. Histopathological and ultrastructural abnormalities were significantly reduced in ETA-treated rats compared to closed head injury trauma groups. CONCLUSIONS: ETA significantly improves neural function and prevents post-TBI histopathological damage in rats.

5.
J Clin Neurosci ; 57: 157-161, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30131196

ABSTRACT

In this study we aimed to examine the effects on wound healing and nerve regeneration of human and rat amniotic membrane wraps around primary epineural anastomosis areas after a peripheral nerve transection injury in rats. We randomized 25 male adult rats with induced peripheral transection injuries into 5 groups (control, transection injury, primary epineural anastomosis [PEA] after injury, PEA with a human amniotic membrane [hAM] wrap, and PEA with a rat amniotic membrane [rAM] wrap groups and treated their injuries accordingly. We took tissue samples from the anastomosis regions, 12 weeks after the experiment, and analyzed them stereologically and ultrastructurally. We performed a statistical analysis with the recovered stereological counts and the measurement data. Our results showed that the use of amniotic membranes for allografts (between same species) instead of xenografts (between different species), along with microsurgery, provides a suitable microenvironment during the healing process with less immunological reaction on the injured site and supports axonal regeneration.


Subject(s)
Amnion/ultrastructure , Anastomosis, Surgical/methods , Microsurgery/methods , Peripheral Nerve Injuries/surgery , Sciatic Nerve/surgery , Amnion/surgery , Anastomosis, Surgical/adverse effects , Animals , Female , Humans , Male , Microsurgery/adverse effects , Nerve Regeneration , Rats , Rats, Sprague-Dawley , Rats, Wistar , Sciatic Nerve/cytology , Sciatic Nerve/physiology , Species Specificity
6.
Turk Neurosurg ; 28(2): 270-274, 2018.
Article in English | MEDLINE | ID: mdl-27943231

ABSTRACT

AIM: In unique clinical situations where C1-C2 posterior fixation is not available or has previously failed, an anterior transarticular screw (ATAS) may be a viable alternative. However, there are no previous reports that investigate possible screw angles, screw entry points, and screw length based on computed tomography (CT) multiplanar reconstruction images in Turkish patients. The aim of this study was to determine the morphometric characteristics C1-C2 vertebrae in order to perform anterior transarticular crossing screw fixation. MATERIAL AND METHODS: Patients who underwent a complete CT scan of the cervical spine for causes other than an investigation of cervical spine malformation or congenital anomaly between the years 2013 and 2015 were included in this study. The anterior transarticular C1-C2 screw angles, screw entry point, and screw length were measured on coronal and sagittal CT multiplanar reconstruction images. RESULTS: Twenty-five male and 14 female patients were included in the study. The mean maximum screw angle for ATAS was found to be 41.18°±4.49°. The minimum and maximum screw lengths were 27.46±3.39 mm and 28.46±3.60 mm, respectively. CONCLUSION: Preoperatively, performing a calculation of the possible screw angles, screw entry point, and screw length based on CT multiplanar reconstruction images for ATAS is a safe and applicable method. In cases in which ATAS fixation across the atlantoaxial joint procedure should be performed without performing a measurement, a screw angle not more than 41.18°±4.49° on the coronal plane does not damage the vertebral artery. Furthermore, using screws shorter than 28.46±3.60 mm doesn"t purchase the atlantoaxial joint.


Subject(s)
Atlanto-Axial Joint/surgery , Bone Screws , Spinal Fusion/instrumentation , Spinal Fusion/methods , Adult , Aged , Cervical Vertebrae/surgery , Female , Humans , Male , Middle Aged , Young Adult
7.
J Craniovertebr Junction Spine ; 8(3): 253-262, 2017.
Article in English | MEDLINE | ID: mdl-29021677

ABSTRACT

LITERATURE REVIEW: In this study, we evaluated a case of primary spinal oligodendroglioma (PSO) with a rare localization between L3 and S2, and also examined sixty cases in the literature in terms of demographic characteristics, clinical, radiological, and histopathological characteristics, and treatment planning. A case of PSO has been presented, and the relevant literature between 1931 and 2016 was reviewed. A total of 57 papers regarding PSO were found and utilized in this review. The main treatment options include radical surgical excision with neuromonitoring, followed by radiotherapy. Despite these treatment protocols, the relapse rate is high, and treatment does not significantly prolong survival. Oligodendrogliomas are rare among the primary spinal cord tumors. Oligodendrogliomas are predominantly found in the cervical spinal cord, thoracic spinal cord, or junctions during childhood and adulthood. Extension to the sacral region, inferior to the Conus, is very rare. Furthermore, of the sixty cases in the literature, the case we present here is the first to be reported in this particular age group. These localizations usually occur in the pediatric age group and after relapses. While for a limited number of cases the oligodendroglioma initiates in the thoracic region and reaches as far as L2, we encountered a case of an oligodendroglioma within the range of L3 to S2. Clinical findings are observed in accordance with location, and magnetic resonance imaging is the gold standard for diagnosis.

8.
J Neurol Surg A Cent Eur Neurosurg ; 78(2): 124-131, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27509316

ABSTRACT

Background This study investigated the effect of Punica granatum L. (pomegranate) juice on the rabbit basilar artery in an experimental subarachnoid hemorrhage (SAH) model. Methods Eighteen adult male New Zealand white rabbits were randomly divided into three groups: a control group (n = 6), SAH group (n = 6), and SAH + treatment group (n = 6). Basilar artery diameter was measured with magnetic resonance angiography (MRA) in all groups at the beginning of the study. Experimental SAH was created by injecting autologous arterial blood into the cisterna magna. In the treatment group, the subjects were administered a daily dose of 30 ml/kg pomegranate juice via gastric gavage for 4 days after the SAH. The SAH group and SAH + treatment group underwent cerebral MRA after 72 hours. After a neurologic score assessment, all the animals were killed. The wall thickness and lumen area of the basilar artery were measured histometrically in all groups, and the apoptotic cell percentage in the artery was identified. The mean diameter of the basilar artery during MRA was measured. Results Pomegranate improved neurologic functions compared with the SAH group (p < 0.01). The mean basilar artery diameter on MRA in the SAH + treatment group was larger than in the SAH group and smaller than in the control group (p < 0.01 and p < 0.05, respectively). The mean vessel wall thickness value in the SAH + treatment group was lower than in the SAH group (p < 0.01), whereas there was no difference between the control and the SAH + treatment group (p > 0.05). The apoptotic cell rate in the SAH + treatment group was significantly lower than in the SAH group (p < 0.001). Evaluation of the basilar artery luminal area showed no difference between the three groups (p > 0.05). Discussion Pomegranate was shown to have a vasospasm- attenuating effect on the basilar artery in the rabbit SAH model for the first time in our study.


Subject(s)
Apoptosis/drug effects , Basilar Artery/drug effects , Fruit and Vegetable Juices , Lythraceae , Phytotherapy/methods , Subarachnoid Hemorrhage/drug therapy , Vasospasm, Intracranial/drug therapy , Animals , Basilar Artery/pathology , Disease Models, Animal , Magnetic Resonance Angiography , Male , Rabbits , Subarachnoid Hemorrhage/complications , Subarachnoid Hemorrhage/pathology , Vasospasm, Intracranial/etiology , Vasospasm, Intracranial/pathology
9.
Turk Neurosurg ; 27(6): 952-961, 2017.
Article in English | MEDLINE | ID: mdl-27476927

ABSTRACT

AIM: To evaluate the effect of pregabalin pre-treatment on spinal cord ischemia-reperfusion (I/R) injury and compare with methylprednisolone (MP). MATERIAL AND METHODS: Thirty-two rats were randomly divided into four groups as follow: Group 1 (sham)(n=8), group 2 (ischemia only)(n=8), group 3 (30 mg/kg pregabalin)(n=8), and group 4 (30 mg/kg methylprednisolone)(n=8). Laparotomy was performed without aortic clamp in the sham group. All animals were sacrificed 24 hours after surgery. The spinal cord tissue samples were harvested and caspase-3 activity, tumor necrosis factor-alpha (TNF-α) and Interleukin-1 Beta (IL-1ß) levels, catalase (CAT) activity, glutathione peroxidase (GPx) activity, superoxide dismutase (SOD) levels malondialdehyde (MDA) levels and nitric oxide (NO) levels were analyzed to investigate the effects of different excitatory and inflammatory pathways in mechanism of I/R injury. Ultrastructural and histopathological examinations were carried out. Neurological recovery was measured by Basso, Beattie, Bresnahan (BBB) test and Inclined Plane Test. RESULTS: Decresead caspase-3 activity and decreased inflammatory markers like TNF-α, IL-1ß, and decresaed excitotatory pathways like CAT, GPx, MDA, NO and SOD were observed in both pregabalin pre-treatment and MP treatment groups. Pregabalin pre-treatment produced better ultrastructural results compared to MP treatment, as with histopathological examination. Pregabalin group showed better recovery compared to MP treament group according to BBB scoring system. CONCLUSION: Pregabalin pre-treatmet and MP treatment both has neuroprotective effect on I/R injury by decreasing caspase dependant apoptosis, and inflammatory and oxidative stress markers. In addition, pregabalin pre-treatment had better clinical effects compared to MP treatment.


Subject(s)
Neuroprotective Agents/pharmacology , Oxidative Stress/drug effects , Pregabalin/pharmacology , Reperfusion Injury/pathology , Spinal Cord Ischemia/pathology , Animals , Apoptosis/drug effects , Male , Methylprednisolone/pharmacology , Rats
10.
Ulus Travma Acil Cerrahi Derg ; 22(3): 253-8, 2016 May.
Article in English | MEDLINE | ID: mdl-27598589

ABSTRACT

BACKGROUND: Gunshot injuries are the third leading cause of spinal injuries, after falls from a significant height and traffic accidents. Severity of spinal damage from gunshot injury depends upon certain mechanical and biological factors. The aim of the present study was to investigate the effect of biological factors on survival in cases of spinal gunshot injury. METHODS: A total of 110 cases of spinal gunshot injury admitted multiple times to emergency services between 2012 and 2014 were included. Age, sex, region of trauma, additional organ or systemic involvement, treatment modalities (conservative, surgical), and mortality rates were analyzed. Effects of biological factors on survival were evaluated. RESULTS: Mean age of the study population was 25.51±11.74 years (min: 4; max: 55) and 95.5% of the population was male. Regions of trauma were thoracic in 50 (45.4%) subjects, cervical in 42 (38.2%), and lumbar in 18 (16.4%). Most common American Spinal Injury Association (ASIA) score was category A, as was found in 77 (70%) cases. No significant correlation was found among age, sex, ASIA score, treatment modality (conservative or surgical), and survival (p>0.05). Additional organ or systemic injury was present in 66 (60%) patients. Additional organ or systemic injury significantly affected survival, independent of the spinal region of trauma (p<0.01). CONCLUSION: Spinal gunshot injuries are complex, with unclear treatment protocol. Irrespective of the indications of spinal surgery, additional organ injuries unfavorably affect survival in cases of spinal gunshot injury. Appropriate management of all biological factors directly affects mortality rate in cases of spinal gunshot injury.


Subject(s)
Spinal Injuries/mortality , Wounds, Gunshot/mortality , Adolescent , Adult , Biological Factors , Child , Child, Preschool , Female , Humans , Injury Severity Score , Male , Middle Aged , Spinal Injuries/diagnostic imaging , Spinal Injuries/pathology , Spinal Injuries/surgery , Survival Analysis , Turkey/epidemiology , Wounds, Gunshot/diagnostic imaging , Wounds, Gunshot/pathology , Wounds, Gunshot/surgery , Young Adult
11.
J Med Food ; 19(6): 601-6, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27183321

ABSTRACT

Garlic has been used as a food as well as a component of traditional medicine. Aged garlic extract (AGE) is claimed to promote human health through antioxidant/anti-inflammatory activities with neuroprotective effects. We evaluated the possible beneficial effect of AGE neurologically, pathologically, ultrastructurally, and biochemically in a spinal cord ischemia-reperfusion (I/R) model of rats. Twenty-four Sprague-Dawley rats were divided into three groups: sham (no I/R), I/R, and AGE (I/R+AGE); each group consisted of eight animals. Animals were evaluated neurologically with the Basso, Beattie, and Bresnahan (BBB) scoring system. The spinal cord tissue samples were harvested for pathological and ultrastructural examinations. Oxidative products (Malondialdehyde, nitric oxide), antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase), inflammatory cytokines (tissue tumor necrosis factor alpha, interleukin-1), and caspase-3 activity were analyzed. The AGE group had significantly higher BBB scores than the I/R group. Pathologically, AGE group revealed reduced degree of ischemia and spinal cord edema. Ultrastructural results also showed preservation of tissue structure in the AGE group. Oxidative product levels of the I/R group were significantly higher than both the other groups, and antioxidant enzyme levels of AGE group were significantly higher than the I/R group. There was also significant difference between the sham and AGE groups in terms of total antioxidant enzyme levels. Furthermore, AGE treatment significantly reduced the inflammatory cytokines and caspase-3 activity than the I/R group. This study demonstrates the considerable neuroprotective effect of AGE on the neurological, pathological, ultrastructural, and biochemical status of rats with I/R-induced spinal cord injury.


Subject(s)
Garlic/chemistry , Neurons/drug effects , Neuroprotective Agents/administration & dosage , Plant Extracts/administration & dosage , Reperfusion Injury/drug therapy , Animals , Caspase 3/metabolism , Disease Models, Animal , Glutathione Peroxidase/metabolism , Humans , Male , Malondialdehyde/metabolism , Neurons/metabolism , Nitric Oxide/metabolism , Rats , Rats, Sprague-Dawley , Spinal Cord/drug effects , Spinal Cord/metabolism , Spinal Cord Ischemia/therapy , Superoxide Dismutase/metabolism , Tumor Necrosis Factor-alpha/metabolism
12.
J Stroke Cerebrovasc Dis ; 25(5): 1196-1207, 2016 May.
Article in English | MEDLINE | ID: mdl-26935117

ABSTRACT

OBJECTIVES: Curcumin is a molecule found in turmeric root that possesses anti-inflammatory and antioxidant properties and has been widely used to treat neurodegenerative diseases. We investigated whether curcumin stimulates the neurorepair process and improves locomotor function in a rat model of spinal cord ischemia-reperfusion injury. METHODS: Thirty-two Wistar albino rats (190-220 g) were randomly allocated into 4 groups of 8 rats each: 1 sham-operated group and 3 ischemia-reperfusion injury groups that received intraperitoneal injections of saline vehicle, methylprednisolone (MP, 30 mg/kg following induction of ischemia-reperfusion [IR] injury), or curcumin (200 mg/kg for 7 days before induction of IR injury). Spinal cord IR injury was induced by occlusion of the abdominal aorta for 30 minutes. After 24 hours of reperfusion, locomotor function was assessed using the Basso, Beattie, and Bresnahan scale. All animals were sacrificed. Spinal cord tissues were harvested to evaluate histopathological and ultrastructural alterations and to analyze levels of malondialdehyde, tumor necrosis factor-alpha, interleukin-1 beta, nitric oxide, and caspase-3, as well as enzyme activities of superoxide dismutase and glutathione peroxidase. RESULTS: Intraperitoneal administration of curcumin significantly reduced inflammatory cytokine expression, attenuated oxidative stress and lipid peroxidation, prevented apoptosis, and increased antioxidant defense mechanism activity in comparison to treatment with MP or saline. Histopathological and ultrastructural abnormalities were significantly reduced in curcumin-treated rats compared to the MP- and saline-treated groups. Furthermore, curcumin significantly improved locomotor function. CONCLUSIONS: Curcumin treatment preserves neuronal viability against inflammation, oxidative stress, and apoptosis associated with ischemia-reperfusion injury.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Curcumin/pharmacology , Inflammation Mediators/metabolism , Neuroprotective Agents/pharmacology , Oxidative Stress/drug effects , Reperfusion Injury/prevention & control , Spinal Cord Ischemia/drug therapy , Spinal Cord/drug effects , Animals , Apoptosis/drug effects , Biomarkers/metabolism , Cytoprotection , Disease Models, Animal , Lipid Peroxidation/drug effects , Locomotion/drug effects , Male , Motor Activity/drug effects , Rats, Wistar , Reperfusion Injury/metabolism , Reperfusion Injury/pathology , Reperfusion Injury/physiopathology , Spinal Cord/metabolism , Spinal Cord/physiopathology , Spinal Cord/ultrastructure , Spinal Cord Ischemia/metabolism , Spinal Cord Ischemia/pathology , Spinal Cord Ischemia/physiopathology , Time Factors
13.
J Neurosurg Spine ; 24(6): 949-59, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26871652

ABSTRACT

OBJECTIVE Ischemia-reperfusion (I/R) injury of the spinal cord following thoracoabdominal aortic surgery remains the most devastating complication, with a life-changing impact on the patient. Thymoquinone (TQ), the main constituent of the volatile oil from Nigella sativa seeds, is reported to possess strong antioxidant, antiinflammatory, and antiapoptotic properties. This study investigated the effects of TQ administration following I/R injury to the spinal cord. METHODS Thirty-two rats were randomly allocated into 4 groups. Group 1 underwent only laparotomy. For Group 2, aortic clip occlusion was introduced to produce I/R injury. Group 3 was given 30 mg/kg of methylprednisolone intraperitoneally immediately after the I/R injury. Group 4 was given 10 mg/kg of TQ intraperitoneally for 7 days before induction of spinal cord I/R injury, and administration was continued until the animal was euthanized. Locomotor function (Basso, Beattie, and Bresnahan scale and inclined plane test) was assessed at 24 hours postischemia. Spinal cord tissue samples were harvested to analyze tissue concentrations of malondialdehyde, nitric oxide, tumor necrosis factor-α, interleukin-1, superoxide dismutase, glutathione-peroxidase, catalase, and caspase-3. In addition, histological and ultrastructural evaluations were performed. RESULTS Thymoquinone treatment improved neurological outcome, which was supported by decreased levels of oxidative products (malondialdehyde and nitric oxide) and proinflammatory cytokines (tumor necrosis factor-α and interleukin-1), increased activities of antioxidant enzymes (superoxide dismutase, glutathione-peroxidase, and catalase), as well as reduction of motor neuron apoptosis. Light microscopy and electron microscopy results also showed preservation of tissue structure in the treatment group. CONCLUSIONS As shown by functional, biochemical, histological, and ultrastructural analysis, TQ exhibits an important protective effect against I/R injury of the spinal cord.


Subject(s)
Apoptosis/drug effects , Benzoquinones/pharmacology , Neuroprotective Agents/pharmacology , Oxidative Stress/drug effects , Reperfusion Injury/drug therapy , Spinal Cord Ischemia/drug therapy , Animals , Antioxidants/metabolism , Apoptosis/physiology , Caspase 3/metabolism , Disease Models, Animal , Interleukin-1/metabolism , Male , Malondialdehyde/metabolism , Motor Neurons/drug effects , Motor Neurons/pathology , Motor Neurons/physiology , Neuroimmunomodulation/drug effects , Neuroimmunomodulation/physiology , Nitric Oxide/metabolism , Oxidative Stress/physiology , Random Allocation , Rats, Wistar , Reperfusion Injury/pathology , Reperfusion Injury/physiopathology , Spinal Cord/drug effects , Spinal Cord/pathology , Spinal Cord/physiopathology , Spinal Cord Ischemia/pathology , Spinal Cord Ischemia/physiopathology , Tumor Necrosis Factor-alpha/metabolism
14.
Injury ; 46(11): 2146-55, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26298021

ABSTRACT

INTRODUCTION: Ganoderma lucidum (G. lucidum) is a mushroom belonging to the polyporaceae family of Basidiomycota and has widely been used as a traditional medicine for thousands of years. G. lucidum has never been studied in traumatic spinal cord injury. The aim of this study is to investigate whether G. lucidum polysaccharides (GLPS) can protect the spinal cord after experimental spinal cord injury. MATERIALS AND METHODS: Rats were randomized into five groups of eight animals each: control, sham, trauma, GLPS, and methylprednisolone. In the control group, no surgical intervention was performed. In the sham group, only a laminectomy was performed. In all the other groups, the spinal cord trauma model was created by the occlusion of the spinal cord with an aneurysm clip. In the spinal cord tissue, caspase-3 activity, tumour necrosis factor-alpha levels, myeloperoxidase activity, malondialdehyde levels, nitric oxide levels, and superoxide dismutase levels were analysed. Histopathological and ultrastructural evaluations were also performed. Neurological evaluation was performed using the Basso, Beattie, and Bresnahan locomotor scale and the inclined-plane test. RESULTS: After traumatic spinal cord injury, increases in caspase-3 activity, tumour necrosis factor-alpha levels, myeloperoxidase activity, malondialdehyde levels, and nitric oxide levels were detected. After the administration of GLPS, decreases were observed in tissue caspase-3 activity, tumour necrosis factor-alpha levels, myeloperoxidase activity, malondialdehyde levels, and nitric oxide levels. Furthermore, GLPS treatment showed improved results in histopathological scores, ultrastructural scores, and functional tests. CONCLUSIONS: Biochemical, histopathological, and ultrastructural analyses and functional tests reveal that GLPS exhibits meaningful neuroprotective effects against spinal cord injury.


Subject(s)
Neuroprotective Agents/pharmacology , Polysaccharides/pharmacology , Reishi/chemistry , Spinal Cord Injuries/pathology , Spinal Cord/pathology , Animals , Disease Models, Animal , Male , Rats , Rats, Wistar , Spinal Cord/drug effects , Spinal Cord Injuries/drug therapy
15.
Spine J ; 15(3): 522-9, 2015 Mar 01.
Article in English | MEDLINE | ID: mdl-25452015

ABSTRACT

BACKGROUND CONTEXT: Epidural fibrosis is a major challenge in spine surgery, with some patients having recurrent symptoms secondary to excessive formation of scar tissue resulting in neurologic compression. One of the most important factors initiating the epidural fibrosis is assumed to be the transforming growth factor-1ß (TGF-1ß). Rosuvastatin (ROS) has shown to demonstrate preventive effects over fibrosis via inhibiting the TGF-1ß. PURPOSE: We hypothesized that ROS might have preventive effects over epidural fibrosis through the inhibition of TGF-1ß pathways. STUDY DESIGN: Experimental animal study. METHODS: Forty-eight adult male Wistar Albino rats were equally and randomly divided into four groups (laminectomy, spongostan, topical ROS, and systemic ROS). Laminectomy was performed at the L3 level in all rats. Four weeks later, the extent of epidural fibrosis was assessed both macroscopically and histopathologically. RESULTS: Our data revealed that topical application and systemic administration of ROS both were effective in reducing epidural fibrosis formation. Furthermore, the systemic administration of ROS yielded better results than topical application. CONCLUSIONS: Both topical application and systemic administration of ROS show meaningful preventive effects over epidural fibrosis through multiple mechanisms. The results of our study provide the first experimental evidence of the preventive effects of ROS over epidural fibrosis.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Cicatrix/prevention & control , Epidural Space/pathology , Fluorobenzenes/administration & dosage , Laminectomy/adverse effects , Pyrimidines/administration & dosage , Sulfonamides/administration & dosage , Transforming Growth Factor beta1/antagonists & inhibitors , Administration, Topical , Animals , Cicatrix/etiology , Disease Models, Animal , Epidural Space/drug effects , Fibrosis , Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage , Intubation, Gastrointestinal , Male , Rats , Rats, Wistar , Rosuvastatin Calcium
16.
J Stroke Cerebrovasc Dis ; 24(1): 83-90, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25440351

ABSTRACT

OBJECTIVES: The aim of this study is to investigate the potential effects of borax on ischemia/reperfusion injury of the rat spinal cord. METHODS: Twenty-one Wistar albino rats were divided into 3 groups: sham (no ischemia/reperfusion), ischemia/reperfusion, and borax (ischemia/reperfusion + borax); each group was consist of 7 animals. Infrarenal aortic cross clamp was applied for 30 minutes to generate spinal cord ischemia. Animals were evaluated functionally with the Basso, Beattie, and Bresnahan scoring system and inclined-plane test. The spinal cord tissue samples were harvested to analyze tissue concentrations of nitric oxide, nitric oxide synthase activity, xanthine oxidase activity, total antioxidant capacity, and total oxidant status and to perform histopathological examination. RESULTS: At the 72nd hour after ischemia, the borax group had significantly higher Basso, Beattie, and Bresnahan and inclined-plane scores than those of ischemia/reperfusion group. Histopathological examination of spinal cord tissues in borax group showed that treatment with borax significantly reduced the degree of spinal cord edema, inflammation, and tissue injury disclosed by light microscopy. Xanthine oxidase activity and total oxidant status levels of the ischemia/reperfusion group were significantly higher than those of the sham and borax groups (P < .05), and total antioxidant capacity levels of borax group were significantly higher than those of the ischemia/reperfusion group (P < .05). There was not a significantly difference between the sham and borax groups in terms of total antioxidant capacity levels (P > .05). The nitric oxide levels and nitric oxide synthase activity of all groups were similar (P > .05). CONCLUSIONS: Borax treatment seems to protect the spinal cord against injury in a rat ischemia/reperfusion model and improve neurological outcome.


Subject(s)
Borates/therapeutic use , Nervous System Diseases/etiology , Nervous System Diseases/prevention & control , Neuroprotective Agents/therapeutic use , Oxidative Stress/drug effects , Reperfusion Injury/complications , Spinal Cord Ischemia/etiology , Spinal Cord Ischemia/prevention & control , Animals , Antioxidants/metabolism , Locomotion/drug effects , Male , Nervous System Diseases/pathology , Nitric Oxide/metabolism , Rats , Rats, Sprague-Dawley , Reperfusion Injury/pathology , Spinal Cord Ischemia/pathology , Xanthine Oxidase/metabolism
17.
Eur J Pharmacol ; 741: 45-54, 2014 Oct 15.
Article in English | MEDLINE | ID: mdl-25084223

ABSTRACT

Rosuvastatin, which is a potent statin, has never been studied in traumatic spinal cord injury. The aim of this study was to investigate whether rosuvastatin treatment could protect the spinal cord after experimental spinal cord injury. Rats were randomized into the following five groups of eight animals each: control, sham, trauma, rosuvastatin, and methylprednisolone. In the control group, no surgical intervention was performed. In the sham group, only laminectomy was performed. In all the other groups, the spinal cord trauma model was created by the occlusion of the spinal cord with an aneurysm clip. In the spinal cord tissue, caspase-3 activity, tumor necrosis factor-alpha levels, myeloperoxidase activity, malondialdehyde levels, nitric oxide levels, and superoxide dismutase levels were analyzed. Histopathological and ultrastructural evaluations were also performed. Neurological evaluation was performed using the Basso, Beattie, and Bresnahan locomotor scale and the inclined-plane test.After traumatic spinal cord injury, increases in caspase-3 activity, tumor necrosis factor-alpha levels, myeloperoxidase activity, malondialdehyde levels, and nitric oxide levels were detected. In contrast, the superoxide dismutase levels were decreased. After the administration of rosuvastatin, decreases were observed in the tissue caspase-3 activity, tumor necrosis factor-alpha levels, myeloperoxidase activity, malondialdehyde levels, and nitric oxide levels. In contrast, tissue superoxide dismutase levels were increased. Furthermore, rosuvastatin treatment showed improved results concerning the histopathological scores, the ultrastructural score and the functional tests. Biochemical, histopathological, ultrastructural analysis and functional tests revealed that rosuvastatin exhibits meaningful neuroprotective effects against spinal cord injury.


Subject(s)
Fluorobenzenes/therapeutic use , Neuroprotective Agents/therapeutic use , Pyrimidines/therapeutic use , Spinal Cord Injuries/pathology , Spinal Cord Injuries/prevention & control , Sulfonamides/therapeutic use , Animals , Male , Rats , Rats, Wistar , Rosuvastatin Calcium , Thoracic Vertebrae , Treatment Outcome
18.
Turk Neurosurg ; 24(4): 519-24, 2014.
Article in English | MEDLINE | ID: mdl-25050676

ABSTRACT

AIM: Astrocytes and extracellular matrix molecules have important roles in regulating synaptic functions between neurons in the central nervous system. However, under pathological conditions, these constituents are activated to form glial scar that is thought to be harmful for neuronal regeneration. The aim of this study was to evaluate the expression pattern of ADAMTS1, -4, -5 and -9 in IL-1 stimulated astrocyte cultures obtained from postnatal day zero mouse brains. MATERIAL AND METHODS: Real time PCR analyses were performed. RESULTS: An overexpression of ADAMTS1, -4, -5 and -9 at the 3-h time point after IL-1 stimulation was found. IL-1 stimulation induced aggrecaneses and this effect was time dependent. Maximum increase was detected at 3-h (six fold increase). Interestingly the expression of ADAMTS1 and -4 appeared to be at the highest expression level but the ADAMTS5 and ADAMTS9 expression level was much weaker (three times and two times respectively). CONCLUSION: To the best of our knowledge, this is the first report demonstrating induction of ADAMTS in IL-1 induced astrocytes. Aggrecanases may play a role in tissue destruction in the progression of central nervous system (CNS) injury and they are differentially expressed in mouse CNS, suggesting a critical role in the pathogenesis of CNS injury. This can be a very crucial aetiologic factor for some neuropsychiatric disorders.


Subject(s)
ADAM Proteins/biosynthesis , Astrocytes/metabolism , Interleukin-1/pharmacology , Procollagen N-Endopeptidase/biosynthesis , ADAMTS1 Protein , ADAMTS4 Protein , ADAMTS5 Protein , ADAMTS9 Protein , Animals , Astrocytes/drug effects , Mice , Polymerase Chain Reaction , Primary Cell Culture
20.
Turk Neurosurg ; 23(6): 811-4, 2013.
Article in English | MEDLINE | ID: mdl-24310469

ABSTRACT

Primary intraosseous arteriovenous malformations (AVM) are not infrequently encountered. We report a case of intraosseous arteriovenous malformation arising in the left temporal bone. A 51-year-old male patient presented with loss of conscious. Computerized tomography displayed hematoma measuring 4 cm in diameter in the left temporal lobe. Digital subtraction angiography (DSA) showed that a temporal bone AVM supplied by all the branches of the external carotid artery and vertebral artery. Many treatment modalities can be considered for preoperative steps and/or for definitive treatment. We preferred embolisation for this vascular pathology. To the best of our knowledge this represents the first case of an intraosseous arteriovenous malformation located in the temporal bone.


Subject(s)
Cerebral Hemorrhage/etiology , Embolization, Therapeutic/methods , Intracranial Arteriovenous Malformations/complications , Petrous Bone/pathology , Temporal Bone/pathology , Angiography, Digital Subtraction , Cerebral Angiography , Cerebral Hemorrhage/pathology , Cerebral Hemorrhage/therapy , Facial Paralysis/etiology , Glasgow Coma Scale , Humans , Intracranial Arteriovenous Malformations/pathology , Intracranial Arteriovenous Malformations/therapy , Male , Middle Aged , Tomography, X-Ray Computed , Unconsciousness/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...